106 related articles for article (PubMed ID: 21173016)
1. Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome.
López-Pedrera C; Ruiz-Limón P; Aguirre MÁ; Barbarroja N; Pérez-Sánchez C; Buendía P; Rodriguez-García IC; Rodriguez-Ariza A; Collantes-Estevez E; Velasco F; Khasmahta M; Cuadrado MJ
Ann Rheum Dis; 2011 Apr; 70(4):675-82. PubMed ID: 21173016
[TBL] [Abstract][Full Text] [Related]
2. Statins for the treatment of antiphospholipid syndrome?
Jajoria P; Murthy V; Papalardo E; Romay-Penabad Z; Gleason C; Pierangeli SS
Ann N Y Acad Sci; 2009 Sep; 1173():736-45. PubMed ID: 19758223
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway.
López-Pedrera C; Buendía P; Cuadrado MJ; Siendones E; Aguirre MA; Barbarroja N; Montiel-Duarte C; Torres A; Khamashta M; Velasco F
Arthritis Rheum; 2006 Jan; 54(1):301-11. PubMed ID: 16385547
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
[TBL] [Abstract][Full Text] [Related]
5. Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein.
Wang HR; Li JJ; Huang CX; Jiang H
Clin Chim Acta; 2005 Mar; 353(1-2):53-60. PubMed ID: 15698590
[TBL] [Abstract][Full Text] [Related]
6. A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients.
Erkan D; Willis R; Murthy VL; Basra G; Vega J; Ruiz-Limón P; Carrera AL; Papalardo E; Martínez-Martínez LA; González EB; Pierangeli SS
Ann Rheum Dis; 2014 Jun; 73(6):1176-80. PubMed ID: 23933625
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future.
Mehdi AA; Uthman I; Khamashta M
Eur J Clin Invest; 2010 May; 40(5):451-64. PubMed ID: 20345380
[TBL] [Abstract][Full Text] [Related]
8. Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells.
Ferrara DE; Swerlick R; Casper K; Meroni PL; Vega-Ostertag ME; Harris EN; Pierangeli SS
J Thromb Haemost; 2004 Sep; 2(9):1558-63. PubMed ID: 15333031
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model.
Ferrara DE; Liu X; Espinola RG; Meroni PL; Abukhalaf I; Harris EN; Pierangeli SS
Arthritis Rheum; 2003 Nov; 48(11):3272-9. PubMed ID: 14613293
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of protease-activated receptors in monocytes from patients with primary antiphospholipid syndrome.
López-Pedrera C; Aguirre MA; Buendía P; Barbarroja N; Ruiz-Limón P; Collantes-Estevez E; Velasco F; Khamashta M; Cuadrado MJ
Arthritis Rheum; 2010 Mar; 62(3):869-77. PubMed ID: 20131237
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis in monocytes of antiphospholipid syndrome patients: deregulation of proteins related to the development of thrombosis.
López-Pedrera C; Cuadrado MJ; Herández V; Buendïa P; Aguirre MA; Barbarroja N; Torres LA; Villalba JM; Velasco F; Khamashta M
Arthritis Rheum; 2008 Sep; 58(9):2835-44. PubMed ID: 18759277
[TBL] [Abstract][Full Text] [Related]
12. More on: fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells.
Pierangeli SS; Ferrara DE
J Thromb Haemost; 2005 May; 3(5):1112-3. PubMed ID: 15869627
[No Abstract] [Full Text] [Related]
13. Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells.
Potena L; Frascaroli G; Grigioni F; Lazzarotto T; Magnani G; Tomasi L; Coccolo F; Gabrielli L; Magelli C; Landini MP; Branzi A
Circulation; 2004 Feb; 109(4):532-6. PubMed ID: 14744969
[TBL] [Abstract][Full Text] [Related]
14. Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure.
Földes G; von Haehling S; Okonko DO; Jankowska EA; Poole-Wilson PA; Anker SD
Int J Cardiol; 2008 Feb; 124(1):80-5. PubMed ID: 17383753
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes.
Takahashi HK; Mori S; Iwagaki H; Yoshino T; Tanaka N; Weitz-Schmidt G; Nishibori M
J Leukoc Biol; 2005 Mar; 77(3):400-7. PubMed ID: 15618295
[TBL] [Abstract][Full Text] [Related]
16. Focal seizures after treatment with fluvastatin in a patient with a history of catastrophic antiphospholipid syndrome.
Miesbach W; Chapman J; Scharrer I
J Neurol Sci; 2005 Nov; 238(1-2):93-5. PubMed ID: 16111706
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression.
Agmon-Levin N; Blank M; Zandman-Goddard G; Orbach H; Meroni PL; Tincani A; Doria A; Cervera R; Miesbach W; Stojanovich L; Barak V; Porat-Katz BS; Amital H; Shoenfeld Y
Ann Rheum Dis; 2011 Jan; 70(1):145-50. PubMed ID: 20980705
[TBL] [Abstract][Full Text] [Related]
18. Fluvastatin inhibits raft dependent Fcgamma receptor signalling in human monocytes.
Hillyard DZ; Jardine AG; McDonald KJ; Cameron AJ
Atherosclerosis; 2004 Feb; 172(2):219-28. PubMed ID: 15019531
[TBL] [Abstract][Full Text] [Related]
19. More on: Fluvastatin inhibits upregulation of tissue factor expression by antiphospholipid antibodies on endothelial cells.
Musial J; Rys D; Brozek J; Swadzba J; Iwaniec T
J Thromb Haemost; 2005 Mar; 3(3):614-5; author reply. PubMed ID: 15748273
[No Abstract] [Full Text] [Related]
20. In vitro effects of antiphospholipid syndrome-IgG fractions and human monoclonal antiphospholipid IgG antibody on human umbilical vein endothelial cells and monocytes.
Clemens N; Frauenknecht K; Katzav A; Sommer C; von Landenberg P
Ann N Y Acad Sci; 2009 Sep; 1173():805-13. PubMed ID: 19758232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
